NRIX
Nurix Therapeutics, Inc.
Revenue to net incomeLast 12 months
Key figures
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $702M | +36.3% |
| Operating income | $290M | — |
| Net income | $295M | — |
| EPS | $2.31 | — |
| Free cash flow | $370M | — |
Nurix Therapeutics, Inc.
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $702M | +36.3% |
| Operating income | $290M | — |
| Net income | $295M | — |
| EPS | $2.31 | — |
| Free cash flow | $370M | — |